胆固醇在心血管疾病中的作用
Errol Moras1, Lakshmi Subramanian2, Francisco Romeo3
1From the Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
低剂量胆固醇表明作为针对心血管疾病的向抗炎疗法具有前途,减少主要心血管不良事件. 仔细监测副作用和药物相互作用对于患者的安全和有效使用至关重要.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 炎症研究 炎症研究
背景情况:
- 炎症是动脉样硬化和心血管疾病的关键驱动因素.
- 传统上用于痛风的素,现在因其抗炎性心血管益处而得到认可.
- 剩余的炎症风险仍然是心血管疾病管理的一个挑战.
研究的目的:
- 审查心血管疾病中黄素的作用机制,标和药理动力学.
- 总结关于胆固醇对心血管疾病的安全性和有效性的证据.
- 为了突出表现素作为一种新的,针对心血管疾病的抗炎疗法.
主要方法:
- 标志性试验和临床研究的综合文献综述.
- 在心血管疾病中分析菌素的分子和生物化学点.
- 评估药理动力学数据和安全性概况,包括不良反应和药物相互作用.
主要成果:
- 具有里程碑意义的试验表明,低剂量的胆固醇可减少主要的不良心血管事件,当添加到标准疗法.
- 科尔奇辛有效地针对传统的风险因素和残留炎症风险.
- 主要的心血管学会认可胆固醇作为一线向性抗炎疗法.
结论:
- 科尔奇辛代表了心血管预防和治疗的新时代.
- 它在冠状动脉疾病,心周炎,心房动和心力衰竭等疾病中的有效性和安全性得到了强有力的证据的支持.
- 密切监测潜在的不良反应和药物相互作用对于优化粉素治疗至关重要.
更多相关视频
08:53Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure Drugs: Inotropic Agents
